Results and Discussion

Slides:



Advertisements
Similar presentations
 AUTHOR- Musiba Baliruno Denis, B.pharm (MUST) SUPERVISORS ;  Prof. K.A.M. Kuria, PhD - Department of Pharmaceutics and Pharmacy Practice, University.
Advertisements

Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Training Workshop on Pharmaceutical Development.
2-5. Formulation Development Issues: Solid Orals Satish Mallya January, 2011.
The Gamlen Tablet Press (GTP) Michael Gamlen Gamlen Tableting Ltd.
By Timina Olive Kayaviri Supervisor : Dr. Amugune
Methods of tablet manufacturing
IRON SUPPLEMENTATION Iron is an essential constituent of the body; necessary for hemoglobin formation and oxidative processes of living tissues. Iron deficiency.
Asthma  Most common chronic illness of childhood, affecting approximately 10% children.  Available preventive therapies for persistent asthma include.
dispersed system Liquid preparations containing undissolved or immiscible drug distributed throughout a vehicle. In these preparations, the substance.
Abwova Veronica Vugutsa B. Pharm
Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science, CDER, FDA An Example of Process Understanding Directed Risk Based CMC Regulatory.
World Health Organization
Multi station rotary presses
Title: Plan for Approach to the Understanding and Predicting Excipient Properties and Functionality NIPTE - National Institute of Pharmaceutical Technology.
Module 1, Part 3: Process validation Slide 1 of 22 © WHO – EDM – 12/2001 Validation Part 3: Process validation Supplementary Training Modules on Good Manufacturing.
OM: if PS is small, add diluent and use blend style Final Formulation: calculate capsule size, % excipients, and final formulation DF: choose excipients.
PHARMACEUTICS- IV (PHT 414 ) Dr. Shahid Jamil SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L /9/2015 Factors Affecting Drug Absorption (Dosage.
Quality control Lecture 1.
Novel Multifunctional Excipients by Co-processing with Mg-Silicate Dr. Faisal Al-Akayleh Faculty of Pharmacy, Petra University.
Formulation factors By Dr. A. S. Adebayo.
<701> DISINTEGRATION
Introduction The following procedure is for the reconstitution of aldoxorubicin drug product for use in the ALDOXORUBICIN-P3-STS-01 study. The reconstitution.
Critical Material Properties for Pharmaceutical Dosage Forms - Industry Perspective Tony Hlinak Abbott Laboratories North Chicago, IL.
Satish Mallya January 20-22, |1 | 2-3. Pharmaceutical Development Satish Mallya Quality Workshop, Copenhagen May 18-21, 2014 May 18-21,2014.
Formulation, Characterization of Pellets of Duloxetine Hydrochloride by Extrusion and Spheronization Prof. V. R. Sinha University Institute of Pharmaceutical.
Introduction What is a Biowaiver?
Liquisolid drug delivery system
Tablet Granulation. Introduction  Granulation is the process in which primary powder particles are made to adhere to form larger, multi particle entities.
Quality control Lecture 1.
Milling Is the reduction in the size mass by conversion of the large solid unit mass into smaller one by mechanical process. This needs energy.
Introduction to Computer Aided Process Planning
TABLET GRANULATION TECHNIQUES.
Integration of Excipients into the Design of Experiments for Pharmaceutical Product and Design Space Development Chris Moreton, Ph.D. FinnBrit Consulting.
Faculty of Pharmacy and Medical Sciences Al-Ahliyya Amman University
Proposal for a Manufacturing Classification System (MCS)
- Pharmaceutical Equivalence Study
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Introduction What is a Biowaiver?
Enabling direct compaction at high drug loading via dry coating of APIs: Towards a predictive framework Presenter(s): Kuriakose T. Kunnath, NJIT Research.
An Artificial Intelligence Approach to Precision Oncology
Gastrointestinal Absorption: Role of the Dosage Form
Wet Granulation.
Biopharmaceutic Considerations in Drug Product Design
IPSA (Industrial Problem Solving Ability )
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Group members: Firdaus | Sofia | Nurainiza | Hafizah
Factors Affecting Drug Absorption (Dosage form factor)
Disintegration test & Dissolution test (official test)
Office of Pharmaceutical Science, CDER, FDA
Quality control Lecture 1.
Quality Control Requirement
J.Preethi*, P. Madhu, K. Arshad Ahmed Khan.
Lab -7- Capsules.
In vitro prediction matches in vivo results
Lab 3 Industrial Pharmacy
Tablet Dosage Form Lab 1.
Lab 3 Industrial pharmacy
Lab4 Industrial pharmacy
Wet Granulation.
Lab -7- Capsules.
Micrometrics. It is the science and technology of small particles. Knowledge and control of the size and the size range of particles are of significant.
Aram I. Ibrahim University of sulaimani College of pharmacy
Tablets Lecturer: dr. Asmaa abdelaziz Mohamed Faculty of pharamcay
Lab3 Industrial Pharmacy
Quality control Lecture 1.
Lab3 Industrial Pharmacy
Formulation factors By Dr. A. S. Adebayo.
University of sulaimani
Tablets.
Primer on Neural networks
Presentation transcript:

Results and Discussion A Hybrid Expert System-Neural Network (“Expert Network”) for Capsule Formulation Support 1Gunjan Kalra, 2Mintong Guo, 1Yun Peng, 2Larry L. Augsburger University of Maryland, Department of Computer Science and Electrical Engineer, Baltimore County; 2 University of Maryland, School of Pharmacy, Baltimore Conclusion Training Data Set Introduction GUI: interface C functions Preliminary results indicate that the PEN is a working system. Good predictive power of the NN module requires sufficient training samples and a cross validation process. The objective was to construct a prototype intelligent hybrid Prototype Expert Network (PEN) for capsule formulation, which may yield formulations meeting specific running and drug delivery performance design criteria for BCS II drugs. To that end, a rule-based expert system (MES) was developed to specifically address BCS Class II drugs and integrated with a neural network (NN). These two components, which comprise the decision module and the prediction module, respectively, are connected together by two information exchange paths to form a loop. The system is believed to have the power to design a suitable capsule formulation to meet both requirements of quality control and dissolution.   Prolog Engine BCS II N CAPEX Y Further research will be directed toward: Validation and refinement of PEN Automation of the parameter adjustment as a process of optimization. Generalization of PEN to other drugs in BCS Class II. CU: calculate PS to meet content-uniformity limit OM: if PS is small, add diluent and use blend style DF: choose excipients types Final Formulation: calculate capsule size, % excipients, and final formulation Acknowledgement This work is being supported by Capsugel. We also gratefully acknowledge Pfizer Central Research for the gift of piroxicam. Input Package Dose/Sol >250? Permeability > 0.0004? Dose Low < 50mg CU Module Eval_HalfDose? Using the given equation to calculate required PS to achieve required tolerance Use New PS Ask Mixing Style from user ? Interactive Physical Blending Liquid Addition CAPEX Diluent MINsol for OM User Input: tapped & bulk density of OM Computer Carr Index Dose Volume > 1000 User Input: Bulk density of dose Compute Carr’ Index Compute Capsule Size Diluent needed? N Y High 100-1000mg Mod 50-100mg V. high >1000mg PS < 10 um Old PS New PS Diluent MPS for OM Choose Disintegrant Choose Lubricant Choose Glidant BCS -IV BCS -I or III BCS -II OM Module DF Module Choose Diluent SSM Flowability Adhere to metal? Lubricant Granulate Fair Bad Good V. Good Low or Medium Large or V. Large Test for DF (Plug Formation) Diluent F-PS Dose Volume >250-1000mL >1000mL Particle Size >150μm Ask User for new particle size >50- 150μm >10-50μm Diluent F-Insol Diluent M-InSol Diluent M-PS Drug Poorly Soluble 250-1000ml Insoluble >1000ml 4% Sodium starch glycolate Croscarmellose 8% Sodium starch glycolate Wettable? Wetting Agent Sodium Lauryl Sulfate Prediction Engine User: Acceptable? N Y Parameter Adjustment Final formulation Predicted dissolution rate for the current formulation Reformulate compute Materials and Method MES Prediction Control ANN result Microcrystalline cellulose (Avicel PH102 (FMC), Emcocel 90M (Penwest)), anhydrous lactose (direct tableting grade, Quest International), piroxicam (donated from Pfizer), magnesium stearate, Explotab (Penwest), Ac-Di-Sol ( FMC) and sodium lauryl sulfate have been used in the study. An instrumented Zanasi LZ-64 was used for the encapsulation process, and the compression force was maintained at 100 ~ 200N to achieve the specific target weight. The plug height was adjusted at 14mm. The dissolution testing was conducted on a Vankel 5000 dissolution station, and followed the USP procedure. The percentage dissolved in 10, 30 and 45 minutes were recorded as the measurements for the dissolution rate. Sixty-three batches have been generated to train and validate the system. A rule-based expert system was developed in Prolog by followed the decision procedures in the flow chat, and integrated with a neural network (NN). These two components, which comprise the decision module and the prediction module, respectively, are connected together by two information exchange paths to form a loop.   Results and Discussion An expert system (MES) in the decision module (based on a decision tree modeled after the Capsugel Expert System1 [CAPEX]) was developed to provide decision rules for formulation recommendation. The NN in the prediction module (using backpropagation learning) was developed to provide predictive capability for the expected outcomes of the recommended formulation. The NN was trained with experiment data to capture the causal associations between the formulation and the outcome. The training was conducted with two experimental datasets using piroxicam as a model drug. The datasets represent two response surface designs for the capsule formulation which were developed to reflect the mapping from such variables as filler type/ratio, lubrication systems, drug particle size/specific surface area, disintegrants and surfactants to dissolution of the model compound. The capsules were filled using dosator-type automatic filling machines. 1 S. Lai, F. Podcek, J.M. Newton, and R. Daumesnil. An expert system to aid the development of capsule formulations. Pharm. Tech. Eur., 8:60-65 (1996).